Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Shanghai Shengdi Pharmaceutical Co., Ltd, explained in plain language.
This study tests a new contrast agent called HRS-9231 for MRI scans of body parts (not the brain). The goal is to see if it makes abnormal blood vessels or lesions show up as clearly as a standard contrast agent. About 309 adults who already need a contrast MRI will receive both …
Phase: PHASE3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Diagnosis
Last updated May 12, 2026 13:42 UTC